In contrast to what has been observed in VL and diffuse cutaneous leishmaniasis, we found neither a type 2 immune response nor an increase in IL-10 levels in DL patients [23,25]. The gene discussed is IL10; the disease is diffuse cutaneous Leishmaniasis.